Search

Search Constraints

You searched for: Author/Creator Pierce, Sherry

Search Results

31. Factors associated with risk of central nervous system relapse in patients with non‐core binding factor acute myeloid leukemia. Issue 9 (19th July 2017)

32. Final results of a phase 2 trial of clofarabine and low‐dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia. Issue 14 (25th March 2015)

33. Final results of a phase 2 trial of clofarabine and low‐dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia. Issue 14 (25th March 2015)

34. Final results of a single institution experience with a pediatric‐based regimen, the augmented Berlin–Frankfurt–Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper‐CVAD regimen. Issue 8 (30th June 2016)

35. Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1‐mutated acute myeloid leukaemia. (22nd February 2021)

36. FLT3 inhibitor based induction and allogeneic stem cell transplant in complete remission 1 improve outcomes in patients with newly diagnosed Acute Myeloid Leukemia with very low FLT3 allelic burden. Issue 8 (8th May 2021)

37. GATA3 rs3824662A allele in B‐cell acute lymphoblastic leukemia in adults, adolescents and young adults: association with CRLF2 rearrangement and poor prognosis. Issue 3 (24th December 2020)

38. Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study. Issue 9 (September 2019)

39. Impact of comorbidities by ACE‐27 in the revised‐IPSS for patients with myelodysplastic syndromes. Issue 5 (21st February 2014)

40. Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia. Issue 4 (19th November 2019)